SEC Form 4 · accession 0001104659-26-103209
Orchestra BioMed Holdings, Inc. · OBIO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Darren Sherman
Officer — See Remarks · Director
Period of report
Aug 26, 2026
Accepted (ET)
Aug 28, 2026 · 4:15 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001814114
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share ("Common Stock") | Aug 26, 2026 | F | 4,925 | $5.26 | D | 1,149,402 | D | |
| Common StockF2 | Aug 26, 2026 | P | 2,000 | $5.33 | A | 2,000 | I | By son |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units ("RSUs"). No shares were sold in the market as a result of the vesting of these RSUs and the satisfaction of tax withholding obligations.
- F2The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Remarks
President and Chief Operating Officer